Irsuc Indications/Uses

For the treatment of iron deficiency in the following indications: Where there is a clinical need for a rapid iron supply; in patients who cannot tolerate oral iron therapy or who are non-compliant; in active inflammatory bowel disease where oral iron preparations are ineffective; in chronic kidney disease when oral iron preparations are less effective.
Iron sucrose Injection USP is indicated for the treatment of iron deficiency in the following indications: Pre-existing (moderate to severe) anemia; patients not responding or having poor compliance with oral iron supplements; pre and postoperative period; postpartum anemia and postpartum haemorrhage; patients with poor iron absorption (bowel operations or diseases); patients with severe renal impairment.
Treatment of Iron Deficiency Anemia in the following patients: Hemodialysis Dependent Chronic Kidney Disease (HDD-CKD) patients receiving an Erythropoietin; Peritoneal Dialysis Dependent Chronic Kidney Disease (PDD-CKD) patients receiving an Erythropoietin; Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD) patients receiving or not receiving an Erythropoietin; During pregnancy and postpartum.